Navigation Links
Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer
Date:5/31/2008

ng a Cotara Phase II safety and efficacy trial in India in GBM patients at first relapse. In patients treated to date, Cotara appears to be safe and well tolerated.

About Cotara(R)

Cotara is an experimental treatment for brain cancer that links a radioactive isotope to a targeted monoclonal antibody. This monoclonal antibody is designed to bind to a type of DNA that is exposed only on dead and dying cells, and solid tumors have many dead and dying cells at their center. Cotara's targeting mechanism enables it to home in on these cells, delivering its radioactive payload directly to the center of the tumor mass and thereby destroying it "from the inside out," with minimal radiation exposure to healthy tissue. Cotara is delivered using convection-enhanced delivery (CED), an NIH-developed method which targets the specific tumor site in the brain. In a previous clinical study, a subset of patients with recurrent glioblastoma treated with Cotara achieved a median survival of 38 weeks, a 58% increase over the median survival time of 24 weeks for patients treated with standard of care therapy. In this study, 25% of 28 recurrent patients survived for more than a year post-treatment and 10% of patients survived for more than three years. These data are considered a promising development in this deadly disease. Cotara has been granted orphan drug status and fast track designation for the treatment of glioblastoma multiforme and anaplastic astrocytoma by the U.S. Food and Drug Administration. Cotara is in a Phase I dosimetry trial in GBM patients in the U.S. and a Phase II safety and efficacy trial in GBM patients in India. For more information on the U.S. clinical trials, visit http://www.clinicaltrials.gov

Poster Number: 5B, Abstract No: 2072: S. Shen, R. Lustig, K.D. Judy, J.B. Fiveash, J. S. Shan, "Open-label, dose confirmation and dosimetry study of Interstitial I 131 I-chTNT-1/ B MAB for the t
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
2. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
4. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
5. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
6. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
7. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
8. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
9. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
10. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
11. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Research and ... (HbA1c) Testing Market" report to their offering. ... rate across the globe. Over 382 million people are estimated ... likely to increase to 592 million by 2035. With ... China and India ...
(Date:9/23/2014)... 2014 The Pennsylvania State Police will accept unwanted, ... part of National Prescription Drug Take-Back Day. The service ... Take-Back Day is a national initiative, conducted in partnership ... encouraging the public to dispose of expired, unused or ... theft. From 10 a.m. to 2 p.m., ...
(Date:9/23/2014)... September 23, 2014 ... the addition of the  "Large Volume Wearable ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... market holds significant potential for the future. ... painful needles to the modern-day pre-filled syringes, ...
Breaking Medicine Technology:Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5
... N.J., Sept. 13, 2011 BD (Becton, Dickinson and ... medical technology company, today announced a commitment to Pink ... and private investments in global health to combat cervical ... Institute, the President,s Emergency Plan for AIDS Relief (PEPFAR), ...
... Calif., Sept. 13, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Officer of BioMarin, will present a company update at the ... September 20, 2011 at 12:30 p.m. ET.   ... conference call via the investor section of the BioMarin website, ...
Cached Medicine Technology:BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 2BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 3BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 4BioMarin to Present at the UBS Global Life Sciences Conference 2
(Date:9/23/2014)... By Kathleen Doheny ... -- For babies born at very low birth weights, breast ... to a potentially dangerous infection known as cytomegalovirus (CMV), a ... very low birth weight infants -- all of whom weighed ... mothers with a history of CMV infection, to see whether ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- Both drinking and ... factors for alcohol abuse by high school students, a ... survey of high school students who drink, could help ... who already drink, to stop them from becoming binge ... between age of first alcohol use and progression to ...
(Date:9/23/2014)... September 23, 2014 What information ... The National Quality Forum (NQF) released a report ... ), and an infographic ( http://bit.ly/1tX3lzA ) resulting ... of healthcare, how patients define affordability, and what ... get the best possible healthcare at the lowest ...
(Date:9/23/2014)... News) -- Few children who take medication for ... the rates vary six-fold across counties in the ... alone can manage symptoms for many children with ... receive behavioral therapy (psychotherapy), the Rand Corp. researchers ... than 1,500 counties across the United States that ...
(Date:9/23/2014)... obese as teenagers could grow up to earn up ... weight. So says Petter Lundborg of Lund University, Paul ... University and Lund University, all in Sweden. The team ... the United States, and the results are published in ... analyzed large-scale data of 145,193 Swedish-born brothers who enlisted ...
Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Note to young men: Fat doesn't pay 2
... satellite imagery also provides crash data in public policy effort ... You can now find the deadliest road in your town ... program that aims to increase public awareness of the need ... Minnesota,s Center for Excellence in Rural Safety (CERS) developed www.saferoadmaps.org, ...
... in the developing world may have substantially underestimated ... findings suggest that policymakers in low-income and middle-income ... impact that dementia places on their health services. ... population increases, dementia and other age-related illnesses are ...
... July 26 The following is a,transcript of the radio ... Good morning. This week, Congress voted to expand a,vital program ... Plan for AIDS Relief, also known as PEPFAR. I thank ... with my Administration to,pass this important bill, and I will ...
... being,issued by the Democratic National Committee:, (Logo: ... of the National Council on Disabilities, and,Bob Kafka, ... today in,advance of John McCain,s appearance via satellite ... Ohio. There is speculation that Senator,McCain will follow ...
... discuss second quarter financial results -, LAVAL, QC, ... today announced that it will host a conference call ... its second quarter 2008,financial results. Labopharm will report its ... 7:00 a.m. the same day., To access the ...
... immune response after antiretroviral therapy may be due to ... A new study challenges the long-held belief that the ... to restore itself after HIV patients are treated with ... to 90 percent of HIV-infected drug users are also ...
Cached Medicine News:Health News:Researchers Map America's Deadliest Roads 2Health News:Prevalence of dementia in the developing world underestimated 2Health News:Prevalence of dementia in the developing world underestimated 3Health News:Radio Address by President Bush to the Nation 2Health News:Radio Address by President Bush to the Nation 3Health News:AUDIO OF CONFERENCE CALL: National Disability Rights Leaders Dubious Over John McCain's Possible Switch on Community Choice Act, Says DNC 2Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2
Cushing-landolt bi-valve speculum for trans-sphenoidal hypophysectomie....
Cushing pituitary scoop, malleable, silver-plated....
... Spinal Implant system. Material that has a ... bone. The result is an implant that ... support, while optimizing the fusion environment through ... anatomic design with 5 and 10 degrees ...
... System provides anterior column support for single ... T1 to L5. The system consists of ... cages that are stacked to a desired ... Carbon Fiber Reinforced Polymer material emulates the ...
Medicine Products: